7/102 sources · 2 publishersUpdated Oct 8, 23:53 UTC
Progyny shares rise after announcing record new covered lives and analyst target increase
Progyny's stock jumped 6% on Oct. 7 after the company said it expects to add a record 1.2 million new covered lives through mid‑2027. The announcement came alongside a Q1 2026 revenue guidance of $325.5 million, which fell short of estimates by 5.1%. Later that day Argus raised its price target for Progyny to $27.00.
Why it matters
The share‑price gain reflects investor optimism about the large influx of new covered lives, which could boost future revenue. Argus' higher target price may further support the stock by signaling a more favorable valuation outlook.
Key facts
- 1Progyny shares rose 6% in the afternoon session. financialcontent.com
- 2The company expects 1.2 million new covered lives by mid‑2027. financialcontent.com
- 3Q1 2026 revenue guidance is $325.5 million, 5.1% below Wall Street expectations. financialcontent.com
- 4Shares are trading at $27.61, 14.7% below the 52‑week high of $32.36. financialcontent.com
- 5Argus raised its target price for Progyny to $27.00. finance.yahoo.com
Summary written by AlphAI from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.